Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
2(20%)
Results Posted
75%(3 trials)
Terminated
1(10%)

Phase Distribution

Ph phase_4
3
30%
Ph phase_3
1
10%
Ph phase_1
2
20%
Ph phase_2
3
30%

Phase Distribution

2

Early Stage

3

Mid Stage

4

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
2(22.2%)
Phase 2Efficacy & side effects
3(33.3%)
Phase 3Large-scale testing
1(11.1%)
Phase 4Post-market surveillance
3(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

10

all time

Status Distribution
Active(2)
Completed(4)
Terminated(1)
Other(3)

Detailed Status

Completed4
unknown3
Terminated1
Active, not recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
2
Success Rate
80.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (22.2%)
Phase 23 (33.3%)
Phase 31 (11.1%)
Phase 43 (33.3%)

Trials by Status

completed440%
terminated110%
unknown330%
active_not_recruiting110%
recruiting110%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
DRUG
Total Trials
10